Evidence map›Paper›PMID 40502128›Full record

ArticlebioRxiv : the preprint server for biology2025

Adenine-induced kidney disease alters the cortical bone metabolome of C57BL/6J mice in a manner that depends on sex.

Shane Stauffer, Hope Welhaven, Brady Hislop, Bryce A Jones, Moshe Levi, Ronald K June, Chelsea M Heveran

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Shane Stauffer
Hope Welhaven
Brady Hislop
Bryce A Jones
Moshe Levi
Ronald K June
Chelsea M Heveran

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic kidney disease (CKD) increases the likelihood of bone fracture as well as post-fracture mortality. The loss of bone fracture resistance in CKD results from both a loss of bone mass and decreased bone material properties, which together result from changes to the health and activities of bone cells. Determining changes to bone tissue metabolism with CKD may reveal insights important to monitoring and mitigating the decrease in bone fracture resistance that commonly occurs as a result of this disease. In this study, untargeted metabolomics was conducted on marrow-flushed cortical tibiae from female and male C57BL/6J mice fed either a control or 0.2% w/w adenine diet. The diets were continued over 3.5 or 7 weeks to produce different severities of kidney injury. Liquid chromatography mass spectrometry (LC-MS) was used to assess metabolites from tibia extracts. Group comparisons (CKD vs control, 7 weeks vs 3.5 weeks, female vs male) were conducted using principal components analysis (PCA), partial least squares discriminant analysis (PLS-DA), and hierarchical clustering. Clusters of metabolites were also assessed using ensemble clustering and cluster optimization analysis (ECCO). Volcano plots and VIP scores were used to identify individual metabolites that differed between groups. Pathway analyses were then conducted from these metabolites. The CKD mice, compared with control mice, had dysregulated essential and nonessential amino acid pathways along with altered pathways associated with sugar and fatty acid metabolism. Compared with mice fed an adenine diet for 3.5 weeks, the mice fed an adenine diet over 7 weeks showed dysregulations in the pentose phosphate pathway along with essential and nonessential amino acid metabolism, porphyrin metabolism, steroid hormone biosynthesis, and other pathways relevant to energy production. Sex differences were apparent in the bone tissue metabolomes of females and males. Compared to males, females experienced dysregulations in essential and nonessential amino acid pathways along with other pathways associated with energy derivation, such as pantothenate and CoA biosynthesis. These results demonstrate that CKD alters bone tissue metabolism and reveals novel insights into metabolic dysregulation in disease as well as important sex differences in these metabolic processes.

Identifiers

PMID40502128
PMCPMC12157587

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.